David Arkowitz Seres Therapeutics, Inc. (MCRB) insider trading activity
David Arkowitz is Chief Financial Officer of Seres Therapeutics, Inc.. Currently has a direct ownership of 182,442 shares of MCRB, which is worth approximately $176,968. The most recent transaction as insider was on Feb 16, 2024, when has been sold 3,939 shares (Common Stock) at a price of $1.08 per share, resulting in proceeds of $4,254. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
182K
0%
3M change
3.8%
12M change
Total Value Held
$176,968
David Arkowitz Transaction History
Also insider at
DA
David Arkowitz
Chief Financial Officer
Cambridge, MA